Navigation Links
Frost & Sullivan Recognizes the Strong Adaptability of ActiveHealth's CareEngine Solution

MOUNTAIN VIEW, Calif., Oct. 23, 2013 /PRNewswire/ -- Based on its recent analysis of the US market for early intervention and general wellness technologies, Frost & Sullivan recognizes ActiveHealth Management (ActiveHealth®) with the 2013 United States Frost & Sullivan Technology Leadership Award for its CareEngine® System. This intuitive platform enables a smart approach to interventional care. Unlike existing analytics tools, ActiveHealth's system provides deep functionality that better flags gaps in care to help lower employer exposure to care costs, manage large populations and improve outcomes.

While most systems flag fairly rudimentary gaps such as lack of medication adherence, CareEngine's Clinical Decision Support presents approximately 5,000 specific clinical rules that can document and alert for higher-level gaps or undiagnosed conditions within a disease treatment program or even for general wellness monitoring.

"ActiveHealth's unique analytics solution provides exceptional value for engagement programs," said Frost & Sullivan Research Director Daniel Ruppar. "The company's strong focus on clinical measures and the adaptability of the CareEngine platform makes it one of the strongest technology solutions in the market.

CareEngine's architecture is built on an aggregation of approved clinical rules, Health Insurance Portability and Accountability Act (HIPAA)-covered protected health information (PHI), legacy claims and predictive algorithms that can be leveraged for simple population health analytics services, as well as for direct disease management and early intervention programs.

Early intervention is the new hybrid that incorporates the basic elements of outbound monitoring common to traditional disease management with tools that attempt to engage members and patients before they become chronically ill. What sets early intervention apart from disease management is an increased focus on preventive "population" analytics that utilize data to predict the likelihood for specific diseases, some self-reported and others from allowed legacy sources.

However, even with early intervention, the process of cost controls has been challenging as there are insufficient methods to properly rationalize multiple data points coming from the patient, managed care claims records, as well as patient health records.

ActiveHealth addresses these shortcomings with its clinical stratification and identification (CSID) tool, which employs a smart system that draws and merges self-reported healthcare research and analytics (HRA) and claims data. It additionally generates degrees of risk stratification across specific condition areas to help assess not only the type of intervention required for particular individuals, but also associated costs.

"Most traditional disease management programs suffer from poor program adherence or drop-off, which adversely affect not only individual outcomes, but also the broad average improvement statistics for the program," noted Ruppar. "By potentially piggybacking a tailored solution for individuals, the new intervention model could experience both greater adoption and long-term adherence, which is the standard by which most effective programs should be judged."

ActiveHealth is a part of Aetna's Healthagen, which is expected to be a major player in broad-scale population health programs, both through Aetna as well as independently through providers and other national and regional plan systems. Frost & Sullivan expects this to give ActiveHealth the ability to not only deliver its solutions effectively, but also tweak the analytics through access to large-scale claims and multi-point data sources.

Among all its peers in the market, ActiveHealth has made one of the most sizeable investments in its core analytics solution and now is well-positioned to deliver deep clinical care management nationally. Overall, ActiveHealth's unique analytics solutions provide exceptional value for engagement programs in the managed care and employer markets.

Each year, Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing and leveraging new technologies, which significantly impacts both the functionality and the customer value of the new products and applications. The award highlights the high R&D spend toward innovation, its relevance to the industry and the positive impact on brand perception.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About ActiveHealth

ActiveHealth Management empowers better health and wellness. ActiveHealth's integrated population health management solutions are designed to help customers improve health outcomes and lower medical costs. ActiveHealth's data analytics, evidence-based clinical decision support and targeted health and wellness programs help health plans, employers, state and local governments, and physicians engage at-risk individuals, promote better care coordination and enable sustainable health care models. Founded in 1998 and headquartered in New York City, ActiveHealth is an independent subsidiary of (NYSE: AET). To learn more, visit

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:        Gain access to visionary innovation


Frost & Sullivan
Mireya Espinoza
P: 210. 247.3870
F: 210.348.1003

ActiveHealth Management
Mary Mooney
P: 212.479.0301

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
2. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
3. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
4. Frost & Sullivan Research Preview: Top 20 Telehealth Markets
5. Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan
6. Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market
7. MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
8. Frost & Sullivan: Developing Integration Capabilities Presents a Real Opportunity for Vendors in the European CIS Market
9. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
10. Electronic Medical Records Progress from an Enterprise-Centric Solution to a Customer-Specific Application, Finds Frost & Sullivan
11. Frost & Sullivan to Host Complimentary Web Conference: Concerns and Solutions for the Anaesthesia Equipment and Associated Peripherals Market
Post Your Comments:
(Date:11/30/2015)... Cumberland Pharmaceuticals (CPIX), today announced that A.J. Kazimi ... December 3, 2015. TIME: 3:15p.m. ET LINK: ... --> DATE: Thursday, December ... --> --> This will ... to ask the company questions in real-time - both in ...
(Date:11/30/2015)... Nov. 30, 2015 Varian Medical Systems (NYSE: VAR ... educational partnership with Apollo Hospitals Group, the largest hospital chain in ... help train radiation technologists in the country. The MoU was signed ... Knowledge, and Ashok Kakkar , Varian,s India ... India , Varian intends to deploy its Access ...
(Date:11/30/2015)... , November 30, 2015 PFE ... at up to 10 G protein-coupled receptor (GPCR) targets ... to research and develop potential new medicines directed at ... multiple therapeutic areas. --> Heptares Therapeutics ("Heptares"), ... and wholly-owned subsidiary of Sosei Group Corporation ("Sosei"; TSE ...
Breaking Medicine Technology:
(Date:11/30/2015)... Ill. (PRWEB) , ... November 30, 2015 , ... ... Decision Support Solutions, announced at the Radiology Society of North America (RSNA) annual ... have seen over 60% growth from 2014. Throughout 2015, the company has ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... automated breast density assessment and enterprise analytics solutions, here at the 101st ... (South Hall booth #2377). Volpara’s quantitative breast imaging tools enable personalized measurements ...
(Date:11/30/2015)... ... November 30, 2015 , ... It’s inevitable that everyone will experience ... friend, or animal pass away, death lives among us. It is your perspective, however, ... a family of 11 children, author T Sky understands that she may see death ...
(Date:11/30/2015)... , ... November 30, 2015 ... ... is pleased to announce the speakers for “Value-Based Payer-Provider Partnerships: Three Case ... from three innovative value-based care arrangements: Essentia Health and UCare, MissionPoint Health ...
(Date:11/30/2015)... , ... November 30, 2015 , ... The successful filing ... pharmaceutical company. Because it is so important to this key industry segment, Regis Technologies ... your IND Filing” on December 4th at 11am EST. , Federal law does not ...
Breaking Medicine News(10 mins):